The BRCA1 mutations that are endemic to the Slavic population of Russia have not been identified among indigenous peoples, including the Buryats, Tuvinians and Altaians with hereditary breast cancer.
OBJECTIVE:
This study was aimed to identify the mutations that are responsible for the occurrence of hereditary breast cancer in the indigenous population of the Republic of Buryatia.
METHODS:
Mutations in the BRCA1 gene were identified in blood samples by Sanger-based sequencing. RESULTS: We identified 11 polymorphisms (10 SNPs and 1 Indel) and 6 new unclassified sequence variants in the BRCA1 gene. In our study three new sequence variants (c.321T>A, c.366T>A, c.4357+2T>A) were found in position of previously described polymorphisms in dbSNPs: rs80357544 (c.321delT), rs190900046 (c.366T>G), and rs80358152(c.4357+2T>C), respectively. Other three new sequence variants (c.3605A>G, c.1998A>C, and c.80+13A>C) have not been previously described in dbSNP, BIC and Human Gene Mutation Databases.
CONCLUSIONS:
We described six new sequence variants that have never been published in the literature or databases. Further studies are required to confirm the impact of new sequence variants on the risk of breast cancer in the Buryat Mongol population.
BakA., JaniszewskaH., CzarneckaA., HeiseM., M.Pilarskaa A risk of breast cancer in women carriers of constitutional CHEK2 gene mutations, originating from the North Central Poland. Hered Cancer Clin Pract12 (2014), 10.
2.
IyevlevaA.G., SuspitsinE.N., KroezeK., GorodnovaT.V., SokolenkoA.P., et al. Non-founder BRCA1 mutations in Russian breast cancer patients. Cancer Lett298 (2010), 258-63.
3.
LoginovaA.N., PospekhovaN.I., LyubchenkoL.N., BudilovA.V., Zakhar'evV.M., et al. Spectrum of mutations in BRCA1 gene in hereditary forms of breast and ovarian cancer in Russian families. Bull Exp Biol Med136 (2003), 276-278.
4.
SokolenkoA.P., MitiushkinaN.V., BuslovK.G., Bit-SavaE.M., IyevlevaA.G., et al. High frequency of BRCA1 5382insC mutation in Russian breast cancer patients. Eur J Cancer10 (2006), 1380-4.
5.
LeongamornlertD., MahmudN., TymrakiewiczM., SaundersE., DadaevT., et al. Germline BRCA1 mutations increase prostate cancer riskBr J Cancer106 (2012), 1697-701.
6.
CoxD.G., SimardJ., SinnettD., Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. Hum Mol Genet23 (2011), 4732-47.
7.
EcclesD.M., Hereditary cancer: guidelines in clinical practice. Breast and ovarian cancer genetics. Ann Oncol15 (2004), 13338.
8.
BeristainE., GuerraI., VidaurrazagaN., BretonesJ., TejadaM.I., LOH analysis should not be used as a tool to assess whether UVs of BRCA1/2 are pathogenic or not. Fam Cancer9 (2010), 2899290.
9.
BeristainE., VergaraI., BouzasC., GuerraI., TejadaM.I., Breast and ovarian cancer risk evaluation in families with a disease causing mutation in BRCA1/2. J Community Genet1 (2010), 91199.
10.
KaramiF., MehdipourP., A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer. Biomed Res Int.2013 (2013), 928562.
11.
MalevaI., MadjunkovaS., BozhinovskiG., Genetic variation of the BRCA1 and BRCA2 genes in Macedonian patients. Balkan J Med Genet15 (2012), 81-5.
12.
KhitrinskayaI.Y., KharkovV.N., VoevodaM.I., StepanovV.A., Genetic Diversity and Relationships of Populations of Northern Eurasia by Polymorphic Alu Insertions. Molecular Biology48 (2014), 58-68.
13.
BalmacaJ., DiezO., RubioI., CastiglioneM., ESMO Guidelines Working Group. BRCA in breast cancer: ESMO Clinical Practice Guidelines. Ann Oncol21 (2010), 20-22.
14.
LubinskiJ., HuzarskiT., ByrskiT., LynchH.T., CybulskiC., Hereditary Breast Cancer Clinical Study Group. The risk of breast cancer in women with a BRCA1 mutation from North America and Poland. Int J Cancer131 (2012), 2299234.
15.
ChangJ.S., YehR.F., WienckeJ.K., et al. Pathway analysis of single-nucleotide polymorphisms potentially associated with glioblastoma multiforme susceptibility using random forests. Cancer Epidemiol Biomarkers Prev6 (2008), 1368-73.
16.
FigueiredoJ.C., JenniferD.B., DavidV.C., et al. Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: Potential modifying effect of BRCA1/BRCA2 mutation carrier status. Breast Cancer Res Treat3 (2011), 819-829.
17.
KuusistoK.M., BebelA., VihinenM., SchleutkerJ., SallinenS.L., Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals. Breast Cancer Res13 (2011), 1-13.
18.
NeguraL., UhrhammerN., NeguraA., ArtenieV., CaraseviciE., Complete BRCA mutation screening in breast and ovarian cancer predisposition families from a North-Eastern Romanian population. Fam Cancer9 (2010), 519-23.
19.
PereiraL.H., PinedaM.A., RoweW.H., FonsecaL.R., GreeneM.H., et al. The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies. BMC Genet8 (2007), 77-81.
20.
MavaddatN., AntoniouA.C., EastonD.F., ClosasM.G., Genetic susceptibility to breast cancer. Mol Oncol4 (2010), 1744191.
21.
CherdyntsevaN.V., PisarevaL.F., IvanovaA., PanferovaY., MalinovskayaE., et al. Ethnic aspects of hereditary breast cancer in the region of Siberia. Vestn Ross Akad Med Nauk11-12 (2014), 72-79. [Article in Russian].
22.
DalyP.A., Hereditary cancer: guidelines in clinical practice - general overview. Ann Oncol15 (2004), 12115.
23.
FerlaR., CalòV., CascioS., RinaldiG., BadalamentiG., et al. Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol18 (2007), 93-98.
24.
NeuhausenS.L., Founder populations and their uses for breast cancer genetics. Breast Cancer Res2 (2000), 77-81.
25.
QinT.T., ChenT., ZhangQ., DuH.N., ShuY.Q., Association between BRCA1 rs799917 polymorphism and breast cancer risk: A meta-analysis of 19,878 subjects. Biomed Pharmacother68 (2014), 905-10.
26.
MartinkovV.N., SilinA.E., NadyrovE.A., SilinaA.A., MartynenkoS.M., The mutation analysis of the coding region of the BRCA1 gene in patients with breast cancer from Gomel region of Belarus. Medical and Biological Problems of Life Activity2 (2014), 27-33. [Article in Russian].
